Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06449573

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

The aim of the study compare the cardiopulmonary parameters of individuals with asthma with healthy subjects.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hacettepe University

Ankara, Turkey (Türkiye)

Location status: Recruiting

Location contact

Aydan Aslı Aksel Uylar

CONTACT

[email protected]

+90312 ext. 3051576

About this study

It is thought that aerobic capacity of asthmatic individuals decreases due to chronic respiratory disease, especially oxygen consumption. Detailed investigation will be provided with this research.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • No respiratory, cardiovascular and metabolic diseases
  • Regular non-smoker

Exclusion criteria

  • Non-consenting
  • Pregnant women

Treatment and study plan

exercise capacity

Other

cardiopulmonary exercise test used assessment of exercise capacity

Primary outcomes

  1. Exercise capacity

    Time frame: 20 minutes

    Exercise capacity will be assessed by Cardiopulmonary Exercise Test. The test will be performed on a bicycle ergometer. The test will be terminated when the target heart rate is reached or when the patient indicates that they are unable to continue the test. maximal oxygen consumption and the workload achieved will be recorded.

Secondary outcomes

  1. Respiratory muscle strength

    Time frame: 8 minutes

    Inspiratory and expiratory muscle strength will be measured with a mouth pressure measuring device. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright.

  2. Peripheral muscle strength

    Time frame: 5 minutes

    It will be evaluated with a portable manual muscle strength measuring device. Muscle strength of knee extensors will be measured. The measurement will be performed with the patient sitting with his/her back unsupported and his/her hands crossed on his/her chest.

  3. Grip strength

    Time frame: 3 minutes

    It will be evaluated with a portable hand dynamometer. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright. The measurement will be performed with the arm adjacent to the side of the trunk and the forearm parallel to the ground.

  4. Kinesiophobia

    Time frame: 3 minutes

    Tampa Kinesiophobia Scale will be used. A total of 17 questions will be answered in 4-point Likert form. In total, the patient scores between 17-68. A high score indicates high kinesiophobia.

  5. Quality of Life (symptoms, mood, activity limitation, environmental exposure)

    Time frame: 10 minutes

    Asthma Quality of Life Scale will be used for the evaluation. This scale consists of 4 sub-headings including symptoms, mood, activity limitation, environmental exposure and 32 questions. Each item is scored between 1-7. The total score of the scale is calculated by averaging the scores given to the items. The higher the score, the better the quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Aydan Aslı Aksel Uylar

CONTACT

[email protected]

+90312 ext. 3051576

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 10, 2024
Registry last updated
Aug 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.